Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Transfer | 4 | 2015 | 103 | 1.580 |
Why?
|
| Transportation of Patients | 3 | 2021 | 39 | 1.080 |
Why?
|
| Air Ambulances | 2 | 2016 | 27 | 0.960 |
Why?
|
| Critical Illness | 3 | 2015 | 344 | 0.700 |
Why?
|
| Pediatrics | 2 | 2021 | 323 | 0.670 |
Why?
|
| Infection Control | 2 | 2022 | 57 | 0.630 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2014 | 302 | 0.600 |
Why?
|
| Altitude | 2 | 2016 | 17 | 0.570 |
Why?
|
| Manikins | 1 | 2016 | 40 | 0.540 |
Why?
|
| Hospitals, Pediatric | 3 | 2015 | 272 | 0.530 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 55 | 0.520 |
Why?
|
| Patient Care Planning | 1 | 2015 | 79 | 0.510 |
Why?
|
| Resuscitation | 1 | 2015 | 83 | 0.510 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 130 | 0.490 |
Why?
|
| Monitoring, Physiologic | 2 | 2012 | 136 | 0.460 |
Why?
|
| Child | 14 | 2022 | 7341 | 0.460 |
Why?
|
| Checklist | 1 | 2012 | 36 | 0.430 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 117 | 0.420 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2012 | 186 | 0.420 |
Why?
|
| Catheterization | 1 | 2012 | 108 | 0.420 |
Why?
|
| Emergencies | 1 | 2012 | 92 | 0.410 |
Why?
|
| Cross Infection | 1 | 2012 | 107 | 0.410 |
Why?
|
| Emergency Medical Services | 2 | 2013 | 126 | 0.410 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 223 | 0.390 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 127 | 0.360 |
Why?
|
| Oxygen | 1 | 2012 | 361 | 0.340 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2007 | 7 | 0.310 |
Why?
|
| Embolism, Fat | 1 | 2006 | 4 | 0.290 |
Why?
|
| Spinal Fusion | 1 | 2006 | 71 | 0.260 |
Why?
|
| Infant, Newborn | 6 | 2021 | 2907 | 0.250 |
Why?
|
| Brain | 1 | 2012 | 1387 | 0.230 |
Why?
|
| Humans | 17 | 2022 | 54284 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2022 | 4147 | 0.220 |
Why?
|
| Empyema, Pleural | 1 | 2022 | 12 | 0.210 |
Why?
|
| Cause of Death | 2 | 2014 | 165 | 0.210 |
Why?
|
| Pleural Effusion | 1 | 2022 | 38 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2022 | 2604 | 0.180 |
Why?
|
| Adolescent | 7 | 2022 | 6897 | 0.170 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 300 | 0.160 |
Why?
|
| United States | 2 | 2021 | 5217 | 0.150 |
Why?
|
| Infant | 6 | 2022 | 3817 | 0.150 |
Why?
|
| Time Factors | 3 | 2015 | 3213 | 0.150 |
Why?
|
| Male | 10 | 2022 | 27334 | 0.140 |
Why?
|
| Respiratory Mucosa | 1 | 2016 | 14 | 0.140 |
Why?
|
| Female | 10 | 2022 | 28441 | 0.140 |
Why?
|
| Pandemics | 1 | 2021 | 579 | 0.140 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2016 | 22 | 0.140 |
Why?
|
| Blood Flow Velocity | 1 | 2016 | 114 | 0.140 |
Why?
|
| Trachea | 1 | 2016 | 51 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 56 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 49 | 0.130 |
Why?
|
| Equipment Design | 1 | 2016 | 318 | 0.130 |
Why?
|
| Adenovirus Infections, Human | 1 | 2014 | 8 | 0.120 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2014 | 53 | 0.120 |
Why?
|
| Physician Executives | 1 | 2013 | 17 | 0.120 |
Why?
|
| Inservice Training | 1 | 2013 | 41 | 0.120 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 29 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2022 | 6432 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 64 | 0.110 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 83 | 0.110 |
Why?
|
| Safety Management | 1 | 2013 | 49 | 0.110 |
Why?
|
| Benchmarking | 1 | 2013 | 73 | 0.110 |
Why?
|
| Accreditation | 1 | 2013 | 72 | 0.110 |
Why?
|
| Disaster Planning | 1 | 2013 | 57 | 0.110 |
Why?
|
| Altitude Sickness | 1 | 2012 | 8 | 0.110 |
Why?
|
| Aircraft | 1 | 2012 | 12 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 2387 | 0.110 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 62 | 0.110 |
Why?
|
| Length of Stay | 1 | 2015 | 683 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1084 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2013 | 273 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 254 | 0.100 |
Why?
|
| Blood Pressure Monitors | 1 | 2010 | 10 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2013 | 307 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 137 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2012 | 374 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2010 | 51 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2010 | 120 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2013 | 240 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 285 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 321 | 0.080 |
Why?
|
| Young Adult | 4 | 2022 | 4318 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 403 | 0.080 |
Why?
|
| Necrosis | 1 | 2007 | 208 | 0.070 |
Why?
|
| Heart Failure | 1 | 2012 | 541 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2006 | 225 | 0.070 |
Why?
|
| Scoliosis | 1 | 2006 | 58 | 0.070 |
Why?
|
| Quarantine | 1 | 2022 | 16 | 0.050 |
Why?
|
| Arkansas | 2 | 2022 | 2100 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2022 | 124 | 0.050 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 88 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 139 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2022 | 127 | 0.050 |
Why?
|
| Registries | 2 | 2014 | 553 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2012 | 465 | 0.040 |
Why?
|
| Autopsy | 1 | 2014 | 53 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2014 | 37 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2014 | 231 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2014 | 208 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2012 | 735 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 427 | 0.020 |
Why?
|
| Critical Care | 1 | 2012 | 234 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 913 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1543 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 2118 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 1361 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 3935 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5604 | 0.010 |
Why?
|